Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
NCT ID: NCT02131220
Last Updated: 2018-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
362 participants
INTERVENTIONAL
2015-11-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis at Different Time
NCT03137212
Pharmacoinvasive Therapy With Prourokinase
NCT01642667
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction
NCT00611169
Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
NCT03406832
Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients
NCT01109134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prourokinase
Intracoronary bolus infusion of 20mg prourokinase using selective catheter
Prourokinase
20mg intracoronary bolus infusion using selective catheter during PCI
Tirofiban
Intracoronary tirofiban bolus infusion using selective catheter (10ug/kg)
Tirofiban
10ug/kg intracoronary bolus infusion using selective catheter during PCI
Normal saline
Intracoronary saline bolus infusion using selective catheter (20ml)
normal saline
intracoronary bolus infusion using selective catheter during PCI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prourokinase
20mg intracoronary bolus infusion using selective catheter during PCI
Tirofiban
10ug/kg intracoronary bolus infusion using selective catheter during PCI
normal saline
intracoronary bolus infusion using selective catheter during PCI
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients administered a fibrinolytic agent before PCI
* Patients enrolled in clinical trials
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ge Junbo
Director, Dept. of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Junbo Ge, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Zhongshan Hospital, Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiology, Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zhongshan 2012-134
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.